Biofrontera Inc. (BFRI) P/E Ratio, ROE & Key Statistics
$0.59NASDAQ: BFRIMarket Cap $8.81M
Data as of Nov 17, 2026 close · Source: Financial Modeling Prep (methodology)
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Biofrontera Inc. (BFRI), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-1.75
P/B ratioShare price divided by book value per share.
-44.02
P/S ratioMarket value divided by annual revenue.
0.22
PEG ratioP/E divided by the earnings growth rate.
-0.01
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-2.76
EV / RevenueEnterprise value against annual revenue.
0.30
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-57.14%
Free cash flow yieldFree cash flow as a percentage of market value.
-53.37%
Price / free cash flowMarket value divided by free cash flow.
-1.87
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
84.60%
Operating marginRevenue left after operating costs.
-9.50%
Net marginRevenue left after every cost, including tax and interest.
-12.72%
Return on equityProfit as a percentage of shareholders’ equity.
-110.30%
Return on assetsProfit as a percentage of total assets.
-28.60%
Return on capital employedOperating profit against the capital the business uses.
-63.40%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
0.78
Quick ratioThe same, excluding inventory.
0.66
Cash ratioCash alone against current liabilities.
0.50
Debt to equityTotal borrowings against shareholders’ equity.
-31.00
Debt to assetsTotal borrowings against total assets.
0.21
Interest coverageHow many times operating profit covers the interest bill.
-18.41
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
−$0.90
Book value per shareShareholders’ equity divided by shares outstanding.
−$0.02
Market capitalisationShare price times shares outstanding.
$8.81M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$15.40M
EmployeesReported headcount.
92
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Biofrontera Inc. (BFRI) statistics — frequently asked questions
What is Biofrontera Inc.'s P/E ratio?
Biofrontera Inc. (BFRI) trades on a price-to-earnings ratio of -1.75. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Biofrontera Inc.'s return on equity?
Biofrontera Inc. (BFRI) reports a return on equity of -110.30%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Biofrontera Inc. carry?
Biofrontera Inc. (BFRI) has a debt-to-equity ratio of -31.00, which compares total borrowings with shareholders' equity.
What is Biofrontera Inc.'s profit margin?
Biofrontera Inc. (BFRI) keeps -12.72% of revenue as net profit after every cost, including tax and interest.
P/E and ROE of other Medical - Pharmaceuticals stocks